These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

995 related articles for article (PubMed ID: 25545165)

  • 21. Association of acute myeloid leukemia's most immature phenotype with risk groups and outcomes.
    Gerber JM; Zeidner JF; Morse S; Blackford AL; Perkins B; Yanagisawa B; Zhang H; Morsberger L; Karp J; Ning Y; Gocke CD; Rosner GL; Smith BD; Jones RJ
    Haematologica; 2016 May; 101(5):607-16. PubMed ID: 26819054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.
    Daga S; Rosenberger A; Quehenberger F; Krisper N; Prietl B; Reinisch A; Zebisch A; Sill H; Wölfler A
    Cancer Med; 2019 Apr; 8(4):1771-1778. PubMed ID: 30848055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldehyde dehydrogenases in acute myeloid leukemia.
    Smith C; Gasparetto M; Humphries K; Pollyea DA; Vasiliou V; Jordan CT
    Ann N Y Acad Sci; 2014 Mar; 1310():58-68. PubMed ID: 24641679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia.
    Kersten B; Valkering M; Wouters R; van Amerongen R; Hanekamp D; Kwidama Z; Valk P; Ossenkoppele G; Zeijlemaker W; Kaspers G; Cloos J; Schuurhuis GJ
    Br J Haematol; 2016 Apr; 173(2):219-35. PubMed ID: 26814163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker.
    Jan M; Chao MP; Cha AC; Alizadeh AA; Gentles AJ; Weissman IL; Majeti R
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5009-14. PubMed ID: 21383193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.
    de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L
    Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
    Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
    J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance.
    Karantanos T; Jones RJ
    Adv Exp Med Biol; 2019; 1139():153-169. PubMed ID: 31134500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples.
    Pearce DJ; Taussig D; Simpson C; Allen K; Rohatiner AZ; Lister TA; Bonnet D
    Stem Cells; 2005; 23(6):752-60. PubMed ID: 15917471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia.
    Ivanivska TS; Sklyarenko LM; Zavelevich MP; Philchenkov AA; Koval SV; Polishchuk AS; Gluzman DF
    Exp Oncol; 2019 Sep; 41(3):207-209. PubMed ID: 31569935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In Vitro Identification and Characteristics of CD34
    Zhang YH; Yang L; Wang YZ; Kong Y; Zhu HH; Qin YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1289-1294. PubMed ID: 29070097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.
    Pierre-Louis O; Clay D; Brunet de la Grange P; Blazsek I; Desterke C; Guerton B; Blondeau C; Malfuson JV; Prat M; Bennaceur-Griscelli A; Lataillade JJ; Le Bousse-Kerdilès MC
    Stem Cells; 2009 Oct; 27(10):2552-62. PubMed ID: 19650038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
    BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML.
    Garg S; Reyes-Palomares A; He L; Bergeron A; Lavallée VP; Lemieux S; Gendron P; Rohde C; Xia J; Jagdhane P; Müller-Tidow C; Lipka DB; Imren S; Humphries RK; Waskow C; Vick B; Jeremias I; Richard-Carpentier G; Hébert J; Sauvageau G; Zaugg JB; Barabé F; Pabst C
    Blood; 2019 Jul; 134(3):263-276. PubMed ID: 31076446
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.
    Blatt K; Herrmann H; Hoermann G; Willmann M; Cerny-Reiterer S; Sadovnik I; Herndlhofer S; Streubel B; Rabitsch W; Sperr WR; Mayerhofer M; Rülicke T; Valent P
    Clin Cancer Res; 2014 Jul; 20(13):3589-602. PubMed ID: 24799522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance.
    Ran D; Schubert M; Taubert I; Eckstein V; Bellos F; Jauch A; Chen H; Bruckner T; Saffrich R; Wuchter P; Ho AD
    Exp Hematol; 2012 Feb; 40(2):155-65.e1. PubMed ID: 22024109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.
    Ren M; Qin H; Wu Q; Savage NM; George TI; Cowell JK
    Int J Cancer; 2016 Aug; 139(4):836-40. PubMed ID: 27005999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia.
    Gerber JM; Smith BD; Ngwang B; Zhang H; Vala MS; Morsberger L; Galkin S; Collector MI; Perkins B; Levis MJ; Griffin CA; Sharkis SJ; Borowitz MJ; Karp JE; Jones RJ
    Blood; 2012 Apr; 119(15):3571-7. PubMed ID: 22262762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ELMO1 is upregulated in AML CD34+ stem/progenitor cells, mediates chemotaxis and predicts poor prognosis in normal karyotype AML.
    Capala ME; Vellenga E; Schuringa JJ
    PLoS One; 2014; 9(10):e111568. PubMed ID: 25360637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.